Julius Knowles, Director at Keros Therapeutics, Inc. (KROS), sold 51,315 shares at $59.96 ($3.1M) on 2021-02-17, disclosed to the SEC on 2021-02-18.
Open-market sale of $3.1M KROS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.48 | 667 | $39K | 1.2% |
| 2 | $58.48 | 434 | $25K | 0.8% |
| 3 | $59.34 | 1,014 | $60K | 1.9% |
| 4 | $59.34 | 661 | $39K | 1.3% |
| 5 | $59.34 | 1,014 | $60K | 1.9% |
| 6 | $60.23 | 3,999 |
| $241K |
| 7.7% |
| 7 | $60.23 | 2,609 | $157K | 5.0% |
| 8 | $60.23 | 2,609 | $157K | 5.0% |
| 9 | $60.23 | 3,999 | $241K | 7.7% |
| 10 | $60.92 | 90 | $5K | 0.2% |
| 11 | $60.92 | 138 | $8K | 0.3% |
| 12 | $58.74 | 645 | $38K | 1.2% |
| 13 | $58.74 | 421 | $25K | 0.8% |
| 14 | $59.96 | 2,249 | $135K | 4.3% |
| 15 | $59.96 | 3,449 | $207K | 6.6% |
| 16 | $59.96 | 3,449 | $207K | 6.6% |
| 17 | $59.96 | 2,249 | $135K | 4.3% |
| 18 | $60.66 | 1,173 | $71K | 2.3% |
| 19 | $60.66 | 1,173 | $71K | 2.3% |
| 20 | $60.66 | 764 | $46K | 1.5% |
| 21 | $61.80 | 1,201 | $74K | 2.4% |
| 22 | $61.80 | 1,841 | $114K | 3.6% |
| 23 | $61.80 | 1,841 | $114K | 3.6% |
| 24 | $61.80 | 1,201 | $74K | 2.4% |
| 25 | $62.72 | 1,705 | $107K | 3.4% |
| 26 | $62.72 | 1,705 | $107K | 3.4% |
| 27 | $62.72 | 2,613 | $164K | 5.2% |
| 28 | $62.72 | 2,613 | $164K | 5.2% |
| 29 | $60.06 | 150 | $9K | 0.3% |
| 30 | $60.06 | 230 | $14K | 0.4% |
| 31 | $61.68 | 276 | $17K | 0.5% |
| 32 | $61.68 | 180 | $11K | 0.4% |
| 33 | $63.04 | 315 | $20K | 0.6% |
| 34 | $63.04 | 205 | $13K | 0.4% |
| 35 | $64.16 | 845 | $54K | 1.7% |
| 36 | $64.16 | 845 | $54K | 1.7% |
| 37 | $64.17 | 552 | $35K | 1.1% |
| 38 | $65.01 | 75 | $5K | 0.2% |
| 39 | $65.02 | 116 | $8K | 0.2% |
| Total | $60.92 avg | 51,315 | $3.1M | 100% |
| Filing → |
| KROS | SELL | 2022-01-05 | $5.3M | — | Filing → |
| KROS | SELL | 2021-12-03 | $5.1M | — | Filing → |
| KROS | SELL | 2021-11-03 | $3.9M | — | Filing → |